CYP2C18: the orphan in the CYP2C family

Pablo Zubiaur^{1

2}, Andrea Gaedigk^{2

3}

Affiliations

¹ Department of Clinical Pharmacology, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
² Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute (CMRI), Kansas City, MO, USA.
³ School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.

Editorial

Pablo Zubiaur et al. Pharmacogenomics. 2022 Nov.

. 2022 Nov;23(17):913-916.

doi: 10.2217/pgs-2022-0142. Epub 2022 Nov 4.

Pablo Zubiaur^{1

2}, Andrea Gaedigk^{2

3}

¹ Department of Clinical Pharmacology, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de La Princesa, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
² Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute (CMRI), Kansas City, MO, USA.
³ School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.

No abstract available

Keywords: CYP2C18; CYP2C19; pharmacogenetics.

Publication types